These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 32833119

  • 1. Usefulness of subcutaneous implantable cardioverter-defibrillator therapy in patients with Brugada syndrome.
    Shinohara T, Abe I, Hirota K, Kondo H, Fukui A, Akioka H, Teshima Y, Yufu K, Nakagawa M, Takahashi N.
    Heart Vessels; 2021 Feb; 36(2):260-266. PubMed ID: 32833119
    [Abstract] [Full Text] [Related]

  • 2. Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study.
    Russo V, Caturano A, Guerra F, Migliore F, Mascia G, Rossi A, Nesti M, Santobuono VE, Attena E, Tola G, Sciarra L, Conte G, Paoletti Perini A, Francia P, Dendramis G, Palamà Z, Albani S, Ottonelli Ghidini A, Calò L, D'Onofrio A, Baldi E, IBRYD Study Group.
    Heart Vessels; 2023 May; 38(5):680-688. PubMed ID: 36418560
    [Abstract] [Full Text] [Related]

  • 3. Impact of electrocardiogram screening during drug challenge test for the prediction of T-wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.
    Kamakura T, Wada M, Ishibashi K, Inoue YY, Miyamoto K, Okamura H, Nagase S, Noda T, Aiba T, Yasuda S, Kusano K.
    Heart Vessels; 2017 Oct; 32(10):1277-1283. PubMed ID: 28523371
    [Abstract] [Full Text] [Related]

  • 4. Predictors of inappropriate shock in Brugada syndrome patients with a subcutaneous implantable cardiac defibrillator.
    Casu G, Silva E, Bisbal F, Viola G, Merella P, Lorenzoni G, Motta G, Bandino S, Berne P.
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1704-1711. PubMed ID: 33928706
    [Abstract] [Full Text] [Related]

  • 5. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
    Brouwer TF, Yilmaz D, Lindeboom R, Buiten MS, Olde Nordkamp LR, Schalij MJ, Wilde AA, van Erven L, Knops RE.
    J Am Coll Cardiol; 2016 Nov 08; 68(19):2047-2055. PubMed ID: 27810043
    [Abstract] [Full Text] [Related]

  • 6. Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study.
    Conte G, Cattaneo F, de Asmundis C, Berne P, Vicentini A, Namdar M, Scalone A, Klersy C, Caputo ML, Demarchi A, Özkartal T, Salghetti F, Casu G, Passarelli I, Mameli S, Shah D, Burri H, De Ferrari G, Brugada P, Auricchio A.
    Europace; 2022 May 03; 24(5):845-854. PubMed ID: 34499723
    [Abstract] [Full Text] [Related]

  • 7. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
    Sacher F, Probst V, Maury P, Babuty D, Mansourati J, Komatsu Y, Marquie C, Rosa A, Diallo A, Cassagneau R, Loizeau C, Martins R, Field ME, Derval N, Miyazaki S, Denis A, Nogami A, Ritter P, Gourraud JB, Ploux S, Rollin A, Zemmoura A, Lamaison D, Bordachar P, Pierre B, Jaïs P, Pasquié JL, Hocini M, Legal F, Defaye P, Boveda S, Iesaka Y, Mabo P, Haïssaguerre M.
    Circulation; 2013 Oct 15; 128(16):1739-47. PubMed ID: 23995538
    [Abstract] [Full Text] [Related]

  • 8. T-wave oversensing in patients with Brugada syndrome: true bipolar versus integrated bipolar implantable cardioverter defibrillator leads: multicenter retrospective study.
    Rodríguez-Mañero M, de Asmundis C, Sacher F, Arbelo E, Probst V, Castro-Hevia J, Maury P, Rollin A, Lambiase P, García-Bolao I, Chierchia GB, Fukushima Kusano K, Gourraud JB, Schilling R, Kamakura T, Martínez-Sande JL, Haïssaguerre M, González-Juanatey JR, Brugada J, Brugada P.
    Circ Arrhythm Electrophysiol; 2015 Aug 15; 8(4):792-8. PubMed ID: 26041387
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the necessity for cardioverter-defibrillator implantation in elderly patients with Brugada syndrome.
    Kamakura T, Wada M, Nakajima I, Ishibashi K, Miyamoto K, Okamura H, Noda T, Aiba T, Takaki H, Yasuda S, Ogawa H, Shimizu W, Makiyama T, Kimura T, Kamakura S, Kusano K.
    Circ Arrhythm Electrophysiol; 2015 Aug 15; 8(4):785-91. PubMed ID: 26067668
    [Abstract] [Full Text] [Related]

  • 10. Implantable Cardioverter-Defibrillators in Children and Adolescents With Brugada Syndrome.
    Gonzalez Corcia MC, Sieira J, Pappaert G, de Asmundis C, Chierchia GB, La Meir M, Sarkozy A, Brugada P.
    J Am Coll Cardiol; 2018 Jan 16; 71(2):148-157. PubMed ID: 29325638
    [Abstract] [Full Text] [Related]

  • 11. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
    Brouwer TF, Knops RE, Kutyifa V, Barr C, Mondésert B, Boersma LVA, Lambiase PD, Wold N, Jones PW, Healey JS.
    Europace; 2018 Sep 01; 20(FI2):f240-f248. PubMed ID: 29771327
    [Abstract] [Full Text] [Related]

  • 12. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
    Basu-Ray I, Liu J, Jia X, Gold M, Ellenbogen K, DiNicolantonio J, Komócsi A, Vorobcsuk A, Kim J, Afshar H, Lam W, Mathuria N, Razavi M, Rasekh A, Saeed M.
    JACC Clin Electrophysiol; 2017 Dec 26; 3(13):1475-1483. PubMed ID: 29759827
    [Abstract] [Full Text] [Related]

  • 13. Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study.
    Nazer B, Dale Z, Carrassa G, Reza N, Ustunkaya T, Papoutsidakis N, Gray A, Howell SJ, Elman MR, Pieragnoli P, Ricciardi G, Jacoby D, Frankel DS, Owens A, Olivotto I, Heitner SB.
    Heart Rhythm; 2020 Jul 26; 17(7):1107-1114. PubMed ID: 32084597
    [Abstract] [Full Text] [Related]

  • 14. Long-term complications of implantable defibrillator therapy in Brugada syndrome.
    Miyazaki S, Uchiyama T, Komatsu Y, Taniguchi H, Kusa S, Nakamura H, Hachiya H, Isobe M, Hirao K, Iesaka Y.
    Am J Cardiol; 2013 May 15; 111(10):1448-51. PubMed ID: 23433764
    [Abstract] [Full Text] [Related]

  • 15. Effect of diurnal variations in the QRS complex and T waves on the eligibility for subcutaneous implantable cardioverter-defibrillators.
    Miwa N, Nagata Y, Yamaguchi T, Nagase M, Sasaki T, Nozato T, Ashikaga T, Goya M, Hirao K.
    Heart Rhythm; 2019 Jun 15; 16(6):913-920. PubMed ID: 30616021
    [Abstract] [Full Text] [Related]

  • 16. Long-term prognosis of patients with Brugada syndrome and an implanted cardioverter-defibrillator.
    Dores H, Reis Santos K, Adragão P, Moscoso Costa F, Galvão Santos P, Carmo P, Cavaco D, Bello Morgado F, Mendes M.
    Rev Port Cardiol; 2015 Jun 15; 34(6):395-402. PubMed ID: 26028488
    [Abstract] [Full Text] [Related]

  • 17. Brugada syndrome: Eligibility for subcutaneous implantable cardioverter-defibrillator after exercise stress test.
    von Hafe P, Faria B, Dias G, Cardoso F, Alves MJ, Alves A, Rodrigues B, Ribeiro S, Sanfins V, Lourenço A.
    Rev Port Cardiol (Engl Ed); 2021 Jan 15; 40(1):33-38. PubMed ID: 33436324
    [Abstract] [Full Text] [Related]

  • 18. Clinical characteristics and treatment outcomes of patients with Brugada syndrome in northeastern Thailand.
    Makarawate P, Chaosuwannakit N, Vannaprasaht S, Tassaneeyakul W, Sawanyawisuth K.
    Singapore Med J; 2014 Apr 15; 55(4):217-20. PubMed ID: 24763838
    [Abstract] [Full Text] [Related]

  • 19. Surface Electrocardiogram Screening for Subcutaneous Implantable Cardioverter-Defibrillators in Japanese Patients With and Without Brugada Syndrome.
    Kawabata M, Goya M, Sasaki T, Maeda S, Yagishita A, Shirai Y, Kaneko M, Shiohira S, Isobe M, Hirao K.
    Circ J; 2017 Jun 23; 81(7):981-987. PubMed ID: 28367844
    [Abstract] [Full Text] [Related]

  • 20. Patients With Brugada Syndrome and Implanted Cardioverter-Defibrillators: Long-Term Follow-Up.
    Hernandez-Ojeda J, Arbelo E, Borras R, Berne P, Tolosana JM, Gomez-Juanatey A, Berruezo A, Campuzano O, Sarquella-Brugada G, Mont L, Brugada R, Brugada J.
    J Am Coll Cardiol; 2017 Oct 17; 70(16):1991-2002. PubMed ID: 29025556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.